Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Organo
Hamilton / Oakville, Ontario, Canada
- Ownership
- Private
- Development stage
- Other
01
Overview
OrganoBiotech offers proprietary organoid and organ-on-a-chip technologies (IFlowPlate™) that enable modeling of complex human tissue, especially by integrating perfusable blood vessel networks around stem-cell derived organoids, thus providing a more predictive platform for drug screening and disease modeling[2][4][5]. Published in top journals (Advanced Materials, ACS Biomaterials, Lab on a Chip).
- Therapeutic areas
- OncologyNeurologyCardiovascularOther
- Modalities
- Organoid-based assayOrgan-on-a-ChipCell culture-based modelSmall molecule (used for screening/testing)
- Industry
- Non-Drug Biotech
02
Partnerships
Beyond the preview
Go deeper on Organo.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Organo.